Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer

被引:40
|
作者
Kim, Jung Ho [1 ]
Hwang, You-Jin [2 ]
Han, Sang Hoon [3 ]
Lee, Young Eun [1 ]
Kim, Saerom [1 ]
Kim, Yoon Jae [1 ]
Cho, Jae Hee [1 ]
Kwon, Kwang An [1 ]
Kim, Ju Hyun [1 ]
Kim, Se-Hee [4 ]
机构
[1] Gachon Univ, Gil Med Ctr, Dept Internal Med, Inchon 405760, South Korea
[2] Gachon Univ Med & Sci, Div Biol Sci, Inchon 406799, South Korea
[3] Jeju Natl Univ, Sch Med, Dept Internal Med, Jeju Si 890716, South Korea
[4] Gachon Univ, Gil Med Ctr, Gachon Med Res Inst, Inchon 405760, South Korea
关键词
Dexamethasone; Colon cancer; Hypoxia; Hypoxia-inducible factor-1 alpha; Epithelial-mesenchymal transition; ACUTE LYMPHOBLASTIC-LEUKEMIA; INDUCIBLE FACTOR-I; TUMOR PROGRESSION; GENE-EXPRESSION; STEM-CELLS; GLUCOCORTICOIDS; METASTASIS; SNAIL; PROLIFERATION; TRANSCRIPTION;
D O I
10.3748/wjg.v21.i34.9887
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To elucidate the effects of dexamethasone on hypoxia-induced epithelial-to-mesenchymal transition (EMT) in colon cancer. METHODS: Human colon cancer HCT116 and HT29 cells were exposed to normoxic (21%) and hypoxic (1%) conditions. First, the effect of dexamethasone on cell viability was examined by MTT cell proliferation assay. In order to measure the expression levels of EMT markers (Snail, Slug, Twist, E-cadherin, and integrin alpha V beta 6) and hypoxia-related genes [Hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF)] by dexamethasone, quantitative real-time polymerase chain reaction and western blot analysis were performed. Furthermore, the morphological changes of colon cancer cells and the expression pattern of E-cadherin by dexamethasone were detected through immunocytochemistry. Finally, the effects of dexamethasone on the invasiveness and migration of colon cancer cells were elucidated using matrigel invasion, migration, and wound healing migration assays. RESULTS: Under hypoxia, dexamethasone treatment inhibited HIF-1 alpha protein level and its downstream gene, VEGF mRNA level in the colon cancer cell lines, HCT116 and HT29. In addition, the presence of dexamethasone down-regulated the mRNA levels of hypoxia-induced Snail, Slug, and Twist, all transcriptional factors of EMT, as well as hypoxia-induced integrin alpha V beta 6 protein level, a well-known EMT marker for colon cancer cells. Furthermore, reduced E-cadherin in hypoxic condition was found to be recoverable by treating with dexamethasone in both colon cancer cell lines. Similarly, under hypoxic conditions, dexamethasone restored the growth pattern and morphological phenotype reminiscent of colon cancer cells grown under normoxic conditions; dexamethasone blocked the migration and invasion of both colorectal cancer cell lines in hypoxia. CONCLUSION: Our study suggested that dexamethasone has inhibitory effects on cell migration and invasion by suppressing EMT of colon cancer cell lines in hypoxic condition.
引用
收藏
页码:9887 / 9899
页数:13
相关论文
共 50 条
  • [31] Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer
    Okumura, Yuichiro
    Noda, Takehiro
    Eguchi, Hidetoshi
    Sakamoto, Takuya
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Asaoka, Tadafumi
    Wada, Hiroshi
    Kawamoto, Koichi
    Gotoh, Kunihito
    Kobayashi, Shogo
    Takeda, Yutaka
    Tanemura, Masahiro
    Umeshita, Koji
    Doki, Yuichiro
    Mori, Masaki
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (12) : 3728 - 3737
  • [32] CSN8 is a key regulator in hypoxia-induced epithelial-mesenchymal transition and dormancy of colorectal cancer cells
    Ju, Songwen
    Wang, Feng
    Wang, Yirong
    Ju, Songguang
    MOLECULAR CANCER, 2020, 19 (01)
  • [33] Hypoxia enhances colon cancer migration and invasion through promotion of epithelial-mesenchymal transition
    Hongo, Kumiko
    Tsuno, Nelson H.
    Kawai, Kazushige
    Sasaki, Kazuhito
    Kaneko, Manabu
    Hiyoshi, Masaya
    Murono, Koji
    Tada, Noriko
    Nirei, Takako
    Sunami, Eiji
    Takahashi, Koki
    Nagawa, Hirokazu
    Kitayama, Joji
    Watanabe, Toshiaki
    JOURNAL OF SURGICAL RESEARCH, 2013, 182 (01) : 75 - 84
  • [34] PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells
    Li, Weiping
    Dong, Yongchao
    Zhang, Bin
    Kang, Yindong
    Yang, Xukai
    Wang, He
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 81 : 1 - 6
  • [35] Hispidulin prevents hypoxia-induced epithelial-mesenchymal transition in human colon carcinoma cells (vol 5, pg 1047, 2015)
    Xie, Jing
    Gao, Hui
    Peng, Jianjun
    Han, Yantao
    Chen, Xuehong
    Jiang, Qixiao
    Wang, Chunbo
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (04): : 1271 - 1273
  • [36] Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression
    Qi, Lisha
    Sun, Baocun
    Liu, Zhiyong
    Li, Hui
    Gao, Jun
    Leng, Xue
    CANCER SCIENCE, 2012, 103 (04) : 828 - 835
  • [37] Hypoxia-induced EGFR tyrosine kinase inhibitor resistance is associated with epithelial-mesenchymal transition in NSCLC
    Lu, Yuhong
    Glazer, Peter M.
    CANCER RESEARCH, 2016, 76
  • [38] HIF-1α mediates Hypoxia-induced epithelial-mesenchymal transition in peritoneal mesothelial cells
    Morishita, Yoshiyuki
    Ookawara, Susumu
    Hirahara, Ichiro
    Muto, Shigeaki
    Nagata, Daisuke
    RENAL FAILURE, 2016, 38 (02) : 282 - 289
  • [39] Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1
    Zhou, Guofei
    Dada, Laura A.
    Wu, Minghua
    Kelly, Aileen
    Trejo, Humberto
    Zhou, Qiyuan
    Varga, John
    Sznajder, Jacob I.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2009, 297 (06) : L1120 - L1130
  • [40] Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer
    Chen, Qunwei
    Lin, Wanfu
    Yin, Zifei
    Zou, Yong
    Liang, Shufang
    Ruan, Shanming
    Chen, Peifeng
    Li, Shu
    Shu, Qijin
    Cheng, Binbin
    Ling, Changquan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019